Anavex Life Sciences Corp (AVXL)

[Talon38]

Tred....the FDA/CDER under Janet Woodstock has pushed "basket/master" trials for drugs that have efficacy for diseases with similar MOA's . So in reviewing future successes of A-273 in AZ, PDD and RS, the FDA may follow her lead with collective/connective trial design for some of the diseases covered by the new patent. That would really be moving ahead with accelerated drug development like we have seen the FDA capable of with COVID-19.

One other thing....the continuing argument on whether Anavex will pursue MS. The PR may give some a hint